Dopamine News and Research

Latest Dopamine News and Research

Discovery of dopamine terminal injury in brains of people with HIV dementia

Scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have discovered a key mechanism in the brains of people with human immunodeficiency virus (HIV) dementia.

20 Sep 2004

First indication that Parkinson’s disease can be caused by a defect in a protein

The findings of Finnish scientists with their multinational collaborators shed light to the mechanisms of Parkinson’s disease and early menopause.

8 Sep 2004

Researchers have identified a possible cause of an inherited form of Parkinson's disease

Columbia University Medical Center and Albert Einstein College of Medicine researchers have identified a possible cause of an inherited form of Parkinson's disease, which may be related to more common forms of the disease.

26 Aug 2004

Investigating how young adults with attention deficit hyperactivity disorder process sound

Mary-Claire Hanlon, a Psychology Honours student at the University of Newcastle under the supervision of Dr Frini Karayanidis and Associate Professor Ulrich Schall, is recruiting participants for the study investigating the role of sound and dopaminergic mechanisms (brain chemicals) in people with ADHD.

12 Aug 2004

Scientists have turned procrastinating primates into workaholics by temporarily suppressing a gene in a brain circuit involved in reward learning

Using a new molecular genetic technique, scientists have turned procrastinating primates into workaholics by temporarily suppressing a gene in a brain circuit involved in reward learning. Without the gene, the monkeys lost their sense of balance between reward and the work required to get it, say researchers at the National Institute of Mental Health .

11 Aug 2004

New screening tool prevents wrong patients from receiving Parkinson's surgery

The allure of a new brain surgery technique to relieve the stiffness and shaking caused by Parkinson’s disease may lead to unnecessary operations, University of Florida researchers say, but a new screening tool they developed could prevent potentially dangerous procedures.

9 Aug 2004

Clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease

The four-year clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease, a degenerative disorder of the central nervous system.

3 Aug 2004

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

The finding suggests that a similar therapy might eventually be able to slow the devastating course of Parkinson's disease in humans.

29 Jul 2004

Clinical study compares treatments in early Parkinson's disease

University of Tennessee Health Science Center professor and vice chair of the Department of Neurology, Ronald F. Pfeiffer, M.D., has been an investigator with The Parkinson Study Group (PSG), which recently reported four-year results of a major long-term, multi-center clinical trial.

21 Jul 2004

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

An article in the July issue of the Archives of Neurology reports that the drugs levodopa and pramipexole both appear to be reasonable options as initial therapy for Parkinson disease, but they are associated with different efficacy and adverse effects.

20 Jul 2004

Human ability to generate feelings through imagery could be the key to a breakthrough in the treatment of mental health problems

A leading psychologist has claimed that humans’ ability to generate feelings through imagery – as, for instance, becoming sexually aroused through fantasy - could be the key to a breakthrough in the treatment of a range of mental health problems.

10 Jul 2004

Michael J. Fox Foundation funds $2 million to solve midbrain system mysteries

The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced today that it has awarded approximately $2.1 million to fund 11 research projects

29 Jun 2004

Treating cocaine addiction with a virus

Scientists at The Scripps Research Institute have designed a potentially valuable tool for treating cocaine addiction by creating a modified "phage" virus that soaks up the drug inside the brain.

24 Jun 2004

Implantable chip could serve as a prosthetic retina for people who suffer from age-related blindness

Where other types of chips use electricity to stimulate nerves, this one instead tickles cells with minute amounts of chemicals. Because nerve cells normally communicate with each other by releasing chemicals known as neurotransmitters, the new device points to a more effective way of treating very delicate tissues, such as those in the eye and in the brain.

24 Jun 2004

SPECT imaging helps attention deficit hyperactivity disorder patients

Attention deficit hyperactivity disorder (ADHD) is the most common behavioral disorder in children; it adversely affects performance in school and emotional development, and the symptoms can continue into adulthood.

23 Jun 2004

Embryonic cell implantation improves motor skills in patients with Parkinson's disease

Patients with Parkinson disease (PD) who underwent treatment involving embryonic cell implantation had better motor functioning after their procedures than PD patients who did not receive embryonic cells

21 Jun 2004

Marijuana/Cannabis causes transient schizophrenia-like symptoms

The principal active ingredient in marijuana causes transient schizophrenia-like symptoms ranging from suspiciousness and delusions to impairments in memory and attention, according to a Yale research study.

15 Jun 2004

Drug combination reduces cocaine use

Researchers at the Yerkes National Primate Research Center are the first to demonstrate that a combination of drug therapies targeting the region of the brain that controls drug abuse and addiction significantly reduces cocaine use in nonhuman primates.

15 Jun 2004

Significant vaccine advance for Parkinson’s disease therapy

Scientists at the University of Nebraska Medical Center in Omaha and Columbia University Medical Center in New York have discovered a new vaccine approach that successfully prevents the death of brain cells in a mouse model of Parkinson’s disease.

15 Jun 2004

Neuroscientists have overcome a major obstacle in gene therapy research

Northwestern University neuroscientists have overcome a major obstacle in gene therapy research. They've devised a method that will safely deliver and regulate expression of therapeutic genes introduced into the central nervous system to treat Parkinson's disease and other neurodegenerative diseases.

5 Jun 2004

Dopamine News and Research

Latest Dopamine News and Research

Discovery of dopamine terminal injury in brains of people with HIV dementia

First indication that Parkinson’s disease can be caused by a defect in a protein

Researchers have identified a possible cause of an inherited form of Parkinson's disease

Investigating how young adults with attention deficit hyperactivity disorder process sound

Scientists have turned procrastinating primates into workaholics by temporarily suppressing a gene in a brain circuit involved in reward learning

New screening tool prevents wrong patients from receiving Parkinson's surgery

Clinical trial established that two drugs, levodopa and pramipexole, are both viable initial treatments for Parkinson's disease

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

Clinical study compares treatments in early Parkinson's disease

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

Human ability to generate feelings through imagery could be the key to a breakthrough in the treatment of mental health problems

Michael J. Fox Foundation funds $2 million to solve midbrain system mysteries

Treating cocaine addiction with a virus

Implantable chip could serve as a prosthetic retina for people who suffer from age-related blindness

SPECT imaging helps attention deficit hyperactivity disorder patients

Embryonic cell implantation improves motor skills in patients with Parkinson's disease

Marijuana/Cannabis causes transient schizophrenia-like symptoms

Drug combination reduces cocaine use

Significant vaccine advance for Parkinson’s disease therapy

Neuroscientists have overcome a major obstacle in gene therapy research

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Dopamine News and Research

Latest Dopamine News and Research

Quality, Patient Safety and Innovation Manager at Elsevier

How Bruker worked with the University of Manchester on mapping the dynamics of complex protein

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Newsletters you may be interested in